title: The low levels of circulating hepatocyte growth factor in nephrolithiasis cases: independent from gene polymorphism.
abstract: Environmental and genetic factors are important in development of nephrolithiasis. In a recent study, it has been demonstrated that hepatocyte growth factor (HGF) has an anti-apoptotic effect and thus can reduce the adhesion of calcium oxalate monohydrate crystals to renal epithelial cells. The aim of this study was to evaluate the HGF serum levels and its two gene polymorphisms and possible association of the two in patients with nephrolithiasis. One hundred and five patients with nephrolithiasis and 70 healthy volunteers with similar demographic features were included in this study. Serum HGF levels were measured, and HGF intron 13 C>A (in 102 stone patients and 68 healthy subjects) and intron 14 T>C (in 99 stone patients and 56 healthy subjects) polymorphisms were determined using real-time polymerase chain reaction with TaqMan allelic discrimination method. There were no statistically significant differences in HGF intron 13 C>A and intron 14 T>C polymorphisms between the control and patient groups (X (2) = 1.72 df = 2; p = 0.42, and X (2) = 0.68 df = 2; p = 0.71, respectively). Mean serum HGF concentration was significantly lower in the stone disease patients than in the control subjects (1.05 ± 0.63 pg/mL and 1.35 ± 0.58 ng/mL respectively, p = 0.0001). When allele distribution frequency between stone patients and healthy subjects was compared, there were no significant differences in intron 13 and intron 14 allele distributions between two groups (p = 0.43 and p = 0.44, respectively). It may be concluded from the findings that decrease in HGF levels may play a role in renal stone formation, independent from gene polymorphisms.
authors.affiliation: Department of Biochemistry, School of Medicine, Ataturk University, 25240, Erzurum, Turkey. nurinnisa.ozturk@gmail.com.
authors.forename: Nurinnisa
authors.initials: N
authors.lastname: Ozturk
authors.affiliation: Department of Biochemistry, School of Medicine, Ataturk University, 25240, Erzurum, Turkey.
authors.forename: Hulya
authors.initials: H
authors.lastname: Aksoy
authors.affiliation: Department of Urology, School of Medicine, Ataturk University, Erzurum, Turkey.
authors.forename: Yilmaz
authors.initials: Y
authors.lastname: Aksoy
authors.affiliation: Department of Biochemistry, School of Medicine, Ataturk University, 25240, Erzurum, Turkey.
authors.forename: Abdulkadir
authors.initials: A
authors.lastname: Yildirim
authors.affiliation: Department of Biochemistry, School of Medicine, Ataturk University, 25240, Erzurum, Turkey.
authors.forename: Fatih
authors.initials: F
authors.lastname: Akcay
authors.affiliation: Kocaeli Karamursel State Hospital, Karamursel, Kocaeli, Turkey.
authors.forename: Vefa
authors.initials: V
authors.lastname: Yanmaz
mesh_terms: D016022:Case-Control Studies; D005260:Female; D017228:Hepatocyte Growth Factor / Q000097:blood* / Q000235:genetics; D006801:Humans; D008297:Male; D053040:Nephrolithiasis / Q000097:blood* / Q000235:genetics; D011110:Polymorphism, Genetic
chemical_list: D017228:Hepatocyte Growth Factor
keywords: Gene polymorphism; Hepatocyte growth factor; Nephrolithiasis; Serum hepatocyte growth factor level